Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16291982 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition
Condition: Obesity
Interventions: Drug: rimonabant;   Behavioral: Dietary intervention
2 Completed Obese Patients With Untreated Dyslipidemias
Conditions: Obesity;   Dyslipidemia
Intervention: Drug: Rimonabant (SR141716)

Indicates status has not been verified in more than two years